表紙
市場調査レポート

網膜芽腫:世界の治験レビュー

Retinoblastoma Global Clinical Trials Review, H1, 2014

発行 GlobalData 商品コード 233635
出版日 ページ情報 英文 78 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.95円で換算しております。
Back to Top
網膜芽腫:世界の治験レビュー Retinoblastoma Global Clinical Trials Review, H1, 2014
出版日: 2014年04月24日 ページ情報: 英文 78 Pages
概要

当レポートでは、網膜芽腫に関する臨床研究の最新動向について分析し、疾患の概要をはじめ、地域および主要国における治験の状況、フェーズ(相)・進捗状況別の治験データ、被験者の募集状況、有望なスポンサー、そして各企業・研究機関の治験プロファイルなどの情報を盛り込んで、概略以下の構成でお届けします。

目次

イントロダクション

  • 網膜芽腫
  • 当レポートの概要

各地域における治験状況

  • 各国の治験数と平均被験者数
    • アジア太平洋地域の主要5ヶ国
    • 欧州の主要5ヶ国
    • 北米の主要国
    • 中東アフリカの主要国
    • 中南米の主要5ヶ国

G7諸国での治験

G7諸国での治験:フェーズ(相)別

G7諸国での治験:進捗状況別

E7諸国での治験

E7諸国での治験:フェーズ(相)別

E7諸国での治験:進捗状況別

フェーズ(相)別の治験

  • 進行中の治験:フェーズ別

進捗状況別の治験

一定期間に採用された被験者

スポンサーの種類別の治験

有望なスポンサー

  • 網膜芽腫治療薬の治験に参加している上位企業

有望な薬剤

治験のプロファイル

  • 代表的企業の治験の概要
    • Laboratorio Elea S.A.C.I.F.
  • 代表的な病院・研究機関の治験の概要
    • National Cancer Institute
    • Children's Oncology Group
    • Memorial Sloan Kettering Cancer Center
    • Hadassah Medical Organization
    • Stanford University
    • The University of Texas M. D. Anderson Cancer Center
    • All India Institute of Medical Sciences
    • Sun Yat-sen University
    • Cincinnati Children's Hospital Medical Center

5つの代表的な治験プロファイル

付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC2101CTIDB

GlobalData's clinical trial report, "Retinoblastoma Global Clinical Trials Review, H1, 2014" provides data on the Retinoblastoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Retinoblastoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Retinoblastoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Retinoblastoma
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Retinoblastoma to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Retinoblastoma to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Retinoblastoma
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Prominent Drugs
  • Latest Clinical Trials News on Retinoblastoma
    • Mar 08, 2013: Cellceutix Announces Positive Preclinical Trial Data Of Kevetrin In Retinoblastoma
    • Jan 11, 2012: Researchers Identify New Genetic Target For Treatment Of Childhood Eye Tumor
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Laboratorio Elea S.A.C.I.F. and A
      • Clinical Trial Overview of Laboratorio Elea S.A.C.I.F. and A
      • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • Children's Oncology Group
      • Clinical Trial Overview of Children's Oncology Group
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
      • Hadassah Medical Organization
      • Clinical Trial Overview of Hadassah Medical Organization
      • Stanford University
      • Clinical Trial Overview of Stanford University
      • The University of Texas M. D. Anderson Cancer Center
      • Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
      • All India Institute of Medical Sciences
      • Clinical Trial Overview of All India Institute of Medical Sciences
      • Sun Yat-sen University
      • Clinical Trial Overview of Sun Yat-sen University
      • Cincinnati Children's Hospital Medical Center
      • Clinical Trial Overview of Cincinnati Children's Hospital Medical Center
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Retinoblastoma Therapeutics, Global, Clinical Trials by Region, 2014*
  • Retinoblastoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Retinoblastoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Retinoblastoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Retinoblastoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Retinoblastoma Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Retinoblastoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Retinoblastoma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Retinoblastoma to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Retinoblastoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Retinoblastoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Retinoblastoma to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Retinoblastoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Retinoblastoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Retinoblastoma Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Retinoblastoma Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Retinoblastoma Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Retinoblastoma Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Retinoblastoma Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Retinoblastoma Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Retinoblastoma Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Retinoblastoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Retinoblastoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Retinoblastoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Retinoblastoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Retinoblastoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratorio Elea S.A.C.I.F. and A, 2014*
  • Retinoblastoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Retinoblastoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Oncology Group, 2014*
  • Retinoblastoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014*
  • Retinoblastoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2014*
  • Retinoblastoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014*
  • Retinoblastoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014*
  • Retinoblastoma Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2014*
  • Retinoblastoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2014*
  • Retinoblastoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Cincinnati Children's Hospital Medical Center, 2014*

List of Figures

  • Retinoblastoma Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Retinoblastoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Retinoblastoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Retinoblastoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Retinoblastoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Retinoblastoma Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Retinoblastoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Retinoblastoma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Retinoblastoma to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Retinoblastoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Retinoblastoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Retinoblastoma to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Retinoblastoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Retinoblastoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Retinoblastoma Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Retinoblastoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Retinoblastoma Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Retinoblastoma Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Retinoblastoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Retinoblastoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Retinoblastoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top